GTC Biotherapeutics (fka GTCB)

[go seek]

CD-137, Dr Meade spoke to JL @ ASM (#msg-30243789) on 23 June

Dr. Meade and I had a delightful conversation (lasting about fifty minutes).. Where he explained all about his personal baby CD-137, a complex immune enhancer-inhibitor,,,with many many possibilities in conditions involving the immune system...he seemed particularly excited about athersclerosis (hardening of the arteries) which modern pathophysiologists concede is an inflamatory disease,,but clinicians do not treat it as such...

Would enjoy a corporate presentation on CD-137 by Dr. Meade and others.







"We do take notice of your thoughts and concerns." Dr. Geoffrey Cox, CEO GTC Biotherapeutics